Ischemia Reperfusion Injury Clinical Trial
Official title:
Immune Modulation by Ischemic Pre-conditioning in Healthy Individuals: Intracellular Signalling in Regulatory Cells
The aim of the study is to investigate how phosphorylation of STAT3, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase (ERK) and protein kinase B (AKT) reacts to remote ischemic conditioning (rIC) in healthy humans, which could point to mechanisms by which rIC may protect against ischemia-reperfusion injury (IRI), and if rIC affects immune reactivity.
In rIC brief episodes of non-lethal ischemia and reperfusion in one vascular bed, tissue or
organ, has shown to have protective effects against IRI in various organs. The protective
effect of rIC seems convincing, but to date it is not clear which mechanisms give rIC its
effects, and why effects are absent in some situations. Effects of rIC on the immune system
are also not clear, but important if rIC is used in transplantation and autoimmunity
settings, and also in regards to infection risk. Patients studied have often been given
medical treatment and/or have comorbidities affecting the results.
This project will measure how intracellular phosphorylation of STAT3, p38 MAPK, ERK and AKT,
inflammatory cell patterns and cytokine production react to rIC in healthy humans, and
potentially give a better understanding of the mechanisms that mediate the protective effects
of rIC. The intracellular mediators studied are involved in the initiation of cytokine
production and regulate apoptosis and activation of the inflammatory cells. An altered
balance between leucocytes and their mediators could be of importance for rIC effects,
particularly in transplantation and autoimmunity, and this will be elucidated in our study.
As a secondary end point the investigators will measure the effect of rIC on pulse
variability and blood pressure using a non-invasive device, since evidence regarding these
aspects is sparse, although documented positive effects of rIC have primarily been on the
heart and vascular system.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06369350 -
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
|
Early Phase 1 | |
Withdrawn |
NCT04388761 -
Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI)
|
Phase 1 | |
Completed |
NCT00987974 -
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
|
Phase 4 | |
Recruiting |
NCT04750616 -
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
|
Phase 2 | |
Recruiting |
NCT05992259 -
Auricular Vagus Stimulation and STEMI
|
N/A | |
Completed |
NCT04493983 -
Role of Oxidative Stress in Ovarian Tissue After CO2-pneumoperitoneum Application-induced I/R
|
N/A | |
Completed |
NCT03510793 -
Microcirculation and Anesthesia in Vascular Surgery
|
||
Recruiting |
NCT02845154 -
Intermittent Portal and Graft Purge in Living Donor Liver Transplantation
|
N/A | |
Terminated |
NCT01564095 -
TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion
|
Phase 2/Phase 3 | |
Completed |
NCT03482544 -
The Effect of Pregabalin Given Preoperatively on the Tourniquet Induced Ischemia-reperfusion
|
Phase 4 | |
Not yet recruiting |
NCT05004610 -
Hypertonic Lactate After Cardiac Arrest
|
Phase 2 | |
Completed |
NCT04205253 -
Tongue Depressor-related Ischemia-Reperfusion Injury in Tongue
|
||
Completed |
NCT03410576 -
Perioperative Time Course of MMP-9 and Its Inhibitor During Carotid Artery Stenting and Carotid Endarterectomy
|
N/A | |
Completed |
NCT03743584 -
Hypothermia After Cardiac Arrest - Effects on Myocardial Function and Inflammatory Response.
|
N/A | |
Recruiting |
NCT04005469 -
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
|
Phase 1/Phase 2 | |
Recruiting |
NCT04630535 -
OSA as a Remote Ischemic Preconditioning in Vascular Surgery
|
||
Completed |
NCT01610401 -
The Metformin-FMD Trial
|
Phase 4 | |
Active, not recruiting |
NCT00876902 -
YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation
|
Phase 2 | |
Recruiting |
NCT05430620 -
Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys
|
Phase 3 | |
Not yet recruiting |
NCT03946852 -
Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation
|
N/A |